Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2009 2
2010 1
2011 1
2013 2
2014 2
2015 3
2016 1
2017 1
2018 2
2019 1
2020 2
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment.
Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, Weis J, Jordan K, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Fabi A, et al. Among authors: fatigoni s. Ann Oncol. 2020 Jun;31(6):713-723. doi: 10.1016/j.annonc.2020.02.016. Epub 2020 Mar 12. Ann Oncol. 2020. PMID: 32173483 Free article. No abstract available.
Fatigue, a major still underestimated issue.
Ripamonti CI, Antonuzzo A, Bossi P, Cavalieri S, Roila F, Fatigoni S. Ripamonti CI, et al. Among authors: fatigoni s. Curr Opin Oncol. 2018 Jul;30(4):219-225. doi: 10.1097/CCO.0000000000000451. Curr Opin Oncol. 2018. PMID: 29877886 Review.
[Cancer-related fatigue].
Fatigoni S, Fumi G, Roila F. Fatigoni S, et al. Recenti Prog Med. 2015 Jan;106(1):28-31. doi: 10.1701/1740.18954. Recenti Prog Med. 2015. PMID: 25621777 Italian.
New antiemetic drugs.
Roila F, Fatigoni S. Roila F, et al. Among authors: fatigoni s. Ann Oncol. 2006 Mar;17 Suppl 2:ii96-100. doi: 10.1093/annonc/mdj936. Ann Oncol. 2006. PMID: 16608997 Free article. Review.
New anti-emetic treatments.
Roila F, Garassino M, Fatigoni S. Roila F, et al. Among authors: fatigoni s. Ann Oncol. 2007 Jul;18 Suppl 9:ix43-7. doi: 10.1093/annonc/mdm293. Ann Oncol. 2007. PMID: 17631595 Free article. Review. No abstract available.
Treatment of lung cancer.
Ballatori E, Fatigoni S, Roila F. Ballatori E, et al. Among authors: fatigoni s. N Engl J Med. 2009 Dec 17;361(25):2485; author reply 2486-7. doi: 10.1056/NEJMc0909634. N Engl J Med. 2009. PMID: 20018971 No abstract available.
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
Buti S, Basso U, Giannarelli D, De Giorgi U, Maruzzo M, Iacovelli R, Galli L, Porta C, Carrozza F, Procopio G, Fonarini G, Lo Re G, Santoni M, Sabbatini R, Cusmai A, Zucali PA, Aschele C, Baldini E, Zafarana E, Favaretto A, Leo S, Hamzaj A, Mirabelli R, Nole' F, Zai S, Chini C, Masini C, Fatigoni S, Rocchi A, Tamburini E, Cortellini A, Bersanelli M. Buti S, et al. Among authors: fatigoni s. J Immunother. 2023 Jan 1;46(1):22-26. doi: 10.1097/CJI.0000000000000446. Epub 2022 Nov 4. J Immunother. 2023. PMID: 36472582 Free PMC article.
22 results